Does SITAGLIPTIN Cause Product dose omission? 346 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 346 reports of Product dose omission have been filed in association with SITAGLIPTIN (JANUVIA). This represents 1.7% of all adverse event reports for SITAGLIPTIN.
346
Reports of Product dose omission with SITAGLIPTIN
1.7%
of all SITAGLIPTIN reports
1
Deaths
16
Hospitalizations
How Dangerous Is Product dose omission From SITAGLIPTIN?
Of the 346 reports, 1 (0.3%) resulted in death, 16 (4.6%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 346 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which SITAGLIPTIN Alternatives Have Lower Product dose omission Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE